Intero Biosystems

Curated by Signal

Developer of miniature human organ for preclinical drug development

Overview

Developer of miniature human organ for preclinical drug development. The organoids are designed to recapitulate the structure and function of human organs that allows drugs to be tested on human organs before human clinical trials, mitigating risk, reducing cost in clinical trials, and identifying safer drugs for patients.

Key facts

Founded: 2024
Headquarters: Ann Arbor, United States
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

LabOrders.net
Online platform for COVID-19 screening and results
Health TechnologyUnited States
MyDiabetesHQ
Online community-based social networking platform for diabetes patients
Health TechnologyHouston, United States
Pluggi
Provider of cannabis dispensary management software
Health TechnologySan Francisco, United States

About Intero Biosystems

What does Intero Biosystems do?

Developer of miniature human organ for preclinical drug development.

Where is Intero Biosystems headquartered?

Intero Biosystems is headquartered in Ann Arbor, United States.

When was Intero Biosystems founded?

Intero Biosystems was founded in 2024.

Which sector is Intero Biosystems in?

Intero Biosystems operates in Health Technology.

Who are Intero Biosystems's competitors?

Companies similar to Intero Biosystems include LabOrders.net, MyDiabetesHQ, and Pluggi.